Viewing Study NCT02731560


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2026-02-06 @ 7:06 AM
Study NCT ID: NCT02731560
Status: COMPLETED
Last Update Posted: 2016-04-07
First Post: 2016-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab (RTX) for Disease Modifying Anti Rheumatic Drug (DMARD) Non-responders in Pakistan: The Pakistan Rituximab Study (PARIS)
Sponsor: Prof. Abid Z. Farooqi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pakistan, Rituximab View
None RA View